Skip to main content
. 2021 Jul 31;24:e00128. doi: 10.1016/j.fawpar.2021.e00128

Fig. 3.

Fig. 3

PCR amplicons of CSF samples from the patients. (A) 100 bp ladder marker, (B) positive control - 0.1 ng gDNA of A. cantonensis, (C) positive control - 0.1 ng gDNA of A. malaysiensis, (D—F) A. cantonensis specific amplicon of CSF-A, CSF-B and CSF-C, (G-I) A. malaysiensis specific amplicon of CSF-A, CSF-B and CSF-C, (J and K) negative controls.